Albertsons Might Suffer from Slower Pharmacy Sales Despite Strong Weight-Loss Drug Demand -- Market Talk

Dow Jones
2025/04/12

1252 ET - Albertsons will likely post decent results next week amid a bumpy macro backdrop, UBS analysts say in a research note. The grocery store chain's exposure to tariffs is likely modest, but still important for earnings, the analysts say. UBS also thinks Albertsons' top line performance could have been hit by slower pharmacy industry sales, even if demand for weight-loss drugs remained very strong. "While it's likely making good progress on its strategic initiatives, we expect for it to strike a cautious tone on the call, especially when considering how tariff uncertainty could impact broader consumer behavior," the analysts add. Albertsons slips 0.8%.(sabela.ojea@wsj.com; @sabelaojeaguix)

(END) Dow Jones Newswires

April 11, 2025 12:52 ET (16:52 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10